| Northern Physical Therapy, Llc | |
|
203 State St, Ogdensburg, NY 13669-1403 | |
| (315) 393-2024 | |
| (315) 393-2025 |
| Full Name | Northern Physical Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 203 State St, Ogdensburg, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174624969 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 011013 (New York) | Primary |
| Provider Name | Carli Obermeyer |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1639356561 PECOS PAC ID: 0042389785 Enrollment ID: I20080520000878 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Jeanine R Mclellan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1942301635 PECOS PAC ID: 4587642897 Enrollment ID: I20111202000185 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Joshua D.a. Mannigan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457651697 PECOS PAC ID: 8628381340 Enrollment ID: I20150723007558 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Claire Marie Sweeney |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275085276 PECOS PAC ID: 2860789773 Enrollment ID: I20160921000245 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Jeffrey H Kaplan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1780842377 PECOS PAC ID: 3274811708 Enrollment ID: I20161103000362 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Mindy L Kaplan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1952569543 PECOS PAC ID: 9436439049 Enrollment ID: I20161216000398 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Jennifer M Kean |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1649797788 PECOS PAC ID: 3072887124 Enrollment ID: I20170928000327 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Emily F Mclellan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1639658230 PECOS PAC ID: 2567714389 Enrollment ID: I20181005001588 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Melissa A Coombs |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1447745732 PECOS PAC ID: 9638422595 Enrollment ID: I20181024000338 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Saima Paul |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1851865752 PECOS PAC ID: 2264770387 Enrollment ID: I20190215001629 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Kara L Hanna |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1669079166 PECOS PAC ID: 9133539950 Enrollment ID: I20201106001158 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Sarah A Boston |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1427457670 PECOS PAC ID: 0244643344 Enrollment ID: I20210111001026 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Provider Name | Jennifer L Snyder |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467110403 PECOS PAC ID: 3678966223 Enrollment ID: I20220203001777 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Northern Physical Therapy, Llc 203 State St, Ogdensburg, NY 13669-1403 Ph: (315) 393-2024 | Northern Physical Therapy, Llc 203 State St, Ogdensburg, NY 13669-1403 Ph: (315) 393-2024 |
News Archive
CyDex Pharmaceuticals, Inc. today announced the initiation of patient dosing in the company's Phase 2A clinical trial of its Captisol-Enabled® Melphalan HCL. Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran® by GlaxoSmithKline.
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
Medicare patients with diabetes and cardiovascular disease can significantly reduce both the cost of their medical care and rates of hospitalization by participating in a telephone-based diabetes disease management program, a new study finds. The authors will present their results Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.
An Indiana University physicist and neuroscientist who studies how physical movement can be used to detect autism in children and adults has received support from the National Science Foundation.
› Verified 2 days ago
Dr. Marlise Hernandez Leggett, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 732 Ford St, Stepping Stones, Ogdensburg, NY 13669 Phone: 315-393-3074 Fax: 315-394-7320 | |
Alison Alguire, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 214 King St, Ogdensburg, NY 13669 Phone: 315-713-5660 Fax: 315-393-0055 | |
Mr. Kevin Andrew Moore, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 203 State St, Ogdensburg, NY 13669 Phone: 315-393-2024 Fax: 315-393-2025 | |
Natalie Gilmour, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8101 State Highway 68, Ogdensburg, NY 13669 Phone: 315-393-0730 | |
Megan Elizabeth Morrison, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8101 State Highway 68, Ogdensburg, NY 13669 Phone: 315-393-0730 | |
Jp Physical Therapy Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1010 Franklin St, Ogdensburg, NY 13669 Phone: 315-528-0024 |